Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Anixa Biosciences, Inc./ 10-Q

Quarterly Report · 10-Q

Anixa Biosciences, Inc.

ANIXNASDAQEQUITYCurrent

Quarterly Report

Filed Mar 11, 2025Accepted Mar 11, 2025, 12:20 PM EDTCIK 715446Accession 0001493152-25-009854
View company →Permanent SEC source ↗
Share

Company context

Current securities

ANIXNASDAQ · EQUITY · Current

Recent company filings

  1. 10-Q filingSep 9, 2026
  2. 10-Q filingJun 10, 2026
  3. Submission of Matters to a Vote of Security Holders · Regulation FD DisclosureMar 11, 2026
  4. 10-Q filingMar 9, 2026
  5. Regulation FD DisclosureFeb 9, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗